Cargando…

Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer

Background: The clinical outcome for the individual prostate cancer patient is often difficult to predict, due to lack of reliable independent prognostic biomarkers. We tested DNA ploidy as a prognostic factor for clinical outcome in 186 patients treated with radical prostatectomy. Methods: DNA ploi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pretorius, Maria E., Wæhre, Håkon, Abeler, Vera M., Davidson, Ben, Vlatkovic, Ljiljana, Lothe, Ragnhild A., Giercksky, Karl-Erik, Danielsen, Håvard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2009
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618993/ https://www.ncbi.nlm.nih.gov/pubmed/19633362 http://dx.doi.org/10.3233/CLO-2009-0463

Ejemplares similares

Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer
por: Ersvær, Elin, et al.
Publicado: (2019)

The Prognostic Value of Adaptive Nuclear Texture Features from Patient Gray Level Entropy Matrices in Early Stage Ovarian Cancer
por: Nielsen, Birgitte, et al.
Publicado: (2012)

PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer
por: Cyll, Karolina, et al.
Publicado: (2021)

TCTP Is an Androgen-Regulated Gene Implicated in Prostate Cancer
por: Kaarbø, Mari, et al.
Publicado: (2013)

Correction: TCTP Is an Androgen-Regulated Gene Implicated in Prostate Cancer
por: Kaarbø, Mari, et al.
Publicado: (2015)

A Review of Caveats in Statistical Nuclear Image Analysis
por: Schulerud, Helene, et al.
Publicado: (1998)

Chromatin changes predict recurrence after radical prostatectomy
por: Hveem, Tarjei S, et al.
Publicado: (2016)

Tumour heterogeneity poses a significant challenge to cancer biomarker research
por: Cyll, Karolina, et al.
Publicado: (2017)

Robot-assisted laparoscopic prostatectomy in a 68-year-old patient with previous heart transplantation and pelvic irradiation
por: Axcrona, Karol, et al.
Publicado: (2011)

DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
por: Pradhan, Manohar, et al.
Publicado: (2012)

Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers
por: Hoei-Hansen, Christina E, et al.
Publicado: (2007)

Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki-67) Markers
por: M. Lopes, José, et al.
Publicado: (1998)

Prognostic Value of Adaptive Textural Features–The Effect of Standardizing Nuclear First-Order Gray Level Statistics and Mixing Information from Nuclei Having Different Area
por: Nielsen, Birgitte, et al.
Publicado: (2006)

Chromatin organisation and cancer prognosis: a pan-cancer study
por: Kleppe, Andreas, et al.
Publicado: (2018)

The Use of Fractal Features from the Periphery of Cell Nuclei as a Classification Tool
por: Nielsen, Birgitte, et al.
Publicado: (1999)

The loss of NKX3.1 expression in testicular – and prostate – cancers is not caused by promoter hypermethylation
por: Lind, Guro E, et al.
Publicado: (2005)

Entropy-Based Adaptive Nuclear Texture Features are Independent Prognostic Markers in a Total Population of Uterine Sarcomas
por: Nielsen, Birgitte, et al.
Publicado: (2015)

Prognostic Classification of Early Ovarian Cancer Based on very Low Dimensionality Adaptive Texture Feature Vectors from Cell Nuclei from Monolayers and Histological Sections
por: Nielsen, Birgitte, et al.
Publicado: (2001)

Prognostic impact of genomic instability in colorectal cancer
por: Hveem, T S, et al.
Publicado: (2014)

Epigenetic Markers for Molecular Detection of Prostate Cancer
por: Costa, Vera L., et al.
Publicado: (2007)

Genomic aberrations in borderline ovarian tumors
por: Micci, Francesca, et al.
Publicado: (2010)

Tumor Spreading to the Contralateral Ovary in Bilateral Ovarian Carcinoma Is a Late Event in Clonal Evolution
por: Micci, Francesca, et al.
Publicado: (2010)

Divergent androgen regulation of unfolded protein response pathways drives prostate cancer
por: Sheng, Xia, et al.
Publicado: (2015)

ADAMTS1, CRABP1, and NR3C1 Identified as Epigenetically Deregulated Genes in Colorectal Tumorigenesis
por: Lind, Guro E., et al.
Publicado: (2006)

Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients
por: Diep, Chieu B, et al.
Publicado: (2004)

Novel Genomic Aberrations in Testicular Germ Cell Tumors by Array-CGH, and Associated Gene Expression Changes
por: Skotheim, Rolf I., et al.
Publicado: (2006)

Molecular Characteristics of Malignant Ovarian Germ Cell Tumors and Comparison With Testicular Counterparts: Implications for Pathogenesis
por: Kraggerud, Sigrid Marie, et al.
Publicado: (2013)

Fibroblast Growth Factor Receptor 3 (FGFR3)–Analyses of the S249C Mutation and Protein Expression in Primary Cervical Carcinomas
por: Dai, Haiyan, et al.
Publicado: (2001)

STAMP2 increases oxidative stress and is critical for prostate cancer
por: Jin, Yang, et al.
Publicado: (2015)

Transcriptome instability as a molecular pan-cancer characteristic of carcinomas
por: Sveen, Anita, et al.
Publicado: (2014)

Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
por: Kleivi, Kristine, et al.
Publicado: (2007)

Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin
por: Pinheiro, Manuela, et al.
Publicado: (2010)

The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.
por: Fosså, S. D., et al.
Publicado: (1992)

Promise and Challenge: Markers of Prostate Cancer Detection, Diagnosis and Prognosis
por: Troyer, D. A., et al.
Publicado: (2004)

Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy
por: Lilleby, Wolfgang, et al.
Publicado: (2015)

ANX7 as a Bio-Marker in Prostate and Breast Cancer Progression
por: Srivastava, Meera, et al.
Publicado: (2001)

A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients
por: Salberg, Unn Beate, et al.
Publicado: (2022)

Somatic Mitochondrial DNA Point Mutations Used as Biomarkers to Demonstrate Genomic Heterogeneity in Primary Prostate Cancer
por: Arstad, Christian, et al.
Publicado: (2020)

The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2014)

Comparison of time curves from dynamic (18)F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
por: Tulipan, Andreas Julius, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pq8ma5ebufalb9f0p4riq91v3a